España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Insmed
INSM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$76.75
4.24
5.85%
At close: -
$76.70
-0.05
-0.07%
After Hours: 5:30 PM EDT
Get Report
Comment
Insmed (INSM) Forecast
News
Earnings
Insmed (INSM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Insmed (NASDAQ:INSM) Stock
Insmed Stock (NASDAQ: INSM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 13, 2025
How Is The Market Feeling About Insmed?
Benzinga Insights
Friday, January 10, 2025
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Chris Katje
Insmed Provides Outlook Ahead Of J.P. Morgan ...
Benzinga Newsdesk
Thursday, January 02, 2025
Here's How Much You Would Have Made Owning Insmed Stock In The Last 10 Years
Benzinga Insights
Monday, December 16, 2024
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Benzinga Insights
Tuesday, December 03, 2024
How Is The Market Feeling About Insmed?
Benzinga Insights
Friday, November 22, 2024
Demystifying Insmed: Insights From 7 Analyst Reviews
Benzinga Insights
JP Morgan Maintains Overweight on Insmed, Rai...
Benzinga Newsdesk
Tuesday, November 19, 2024
Energizer, C3.ai, Insmed And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Insmed On Nov. 18 Terminated Sales Agreement ...
Benzinga Newsdesk
Monday, November 18, 2024
Insmed's Options: A Look at What the Big Money is Thinking
Benzinga Insights
Friday, November 08, 2024
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Chris Katje
Friday, November 01, 2024
Truist Securities Reiterates Buy on Insmed, R...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Insmed,...
Benzinga Newsdesk
Thursday, October 31, 2024
Insmed Reiterates Its Guidance For Full-year ...
Benzinga Newsdesk
Insmed Q3 2024 GAAP EPS $(1.27) Misses $(1.21...
Benzinga Newsdesk
Wednesday, October 30, 2024
A Glimpse of Insmed's Earnings Potential
Benzinga Insights
Friday, October 25, 2024
Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today
Benzinga Insights
Thursday, October 24, 2024
Peering Into Insmed's Recent Short Interest
Benzinga Insights
Tuesday, October 15, 2024
Here's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth Today
Benzinga Insights
Friday, October 11, 2024
Truist Securities Maintains Buy on Insmed, Ra...
Benzinga Newsdesk
Wednesday, October 09, 2024
B of A Securities Maintains Buy on Insmed, Ra...
Benzinga Newsdesk
Tuesday, October 08, 2024
Insmed Inc Presents New Subgroup Analyses Fro...
Benzinga Newsdesk
Thursday, October 03, 2024
JP Morgan Maintains Overweight on Insmed, Rai...
Benzinga Newsdesk
Friday, September 20, 2024
Here's How Much You Would Have Made Owning Insmed Stock In The Last 10 Years
Benzinga Insights
Monday, September 16, 2024
Should JPMorgan BetaBuilders U.S. Small Cap Equity ETF Be on Your Investing Radar?
Zacks
(INSM) - Analyzing Insmed's Short Interest
Benzinga Insights
Tuesday, September 10, 2024
Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today
Benzinga Insights
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on In...
Benzinga Newsdesk
Thursday, August 29, 2024
HC Wainwright & Co. Reiterates Buy on Insmed,...
Benzinga Newsdesk
Monday, August 26, 2024
$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today
Benzinga Insights
Friday, August 23, 2024
Watching Shares Of Insmed; Traders Circulatin...
Benzinga Newsdesk
Monday, August 12, 2024
Truist Securities Maintains Buy on Insmed, Lo...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Insmed,...
Benzinga Newsdesk
Friday, August 09, 2024
TD Cowen Maintains Buy on Insmed, Raises Pric...
Benzinga Newsdesk
UBS Maintains Buy on Insmed, Raises Price Tar...
Benzinga Newsdesk
Stifel Maintains Buy on Insmed, Raises Price ...
Benzinga Newsdesk
Thursday, August 08, 2024
$100 Invested In Insmed 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
Insmed shares are trading lower after the com...
Benzinga Newsdesk
Insmed Reiterates 2024 Global Arikayce Revenu...
Benzinga Newsdesk
Insmed Q2 2024 GAAP EPS $(1.94) Misses $(1.24...
Benzinga Newsdesk
Wednesday, July 17, 2024
Here's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth Today
Benzinga Insights
Tuesday, July 16, 2024
Looking Into Insmed's Recent Short Interest
Benzinga Insights
Sunday, July 14, 2024
Rivian Automotive & Baidu Are Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 7-July 13): Are The Others In Your Portfolio?
Lekha Gupta
Friday, July 12, 2024
$1000 Invested In This Stock 10 Years Ago Would Be Worth $4,300 Today
Benzinga Insights
Morgan Stanley Maintains Overweight on Insmed...
Benzinga Newsdesk
Thursday, July 11, 2024
Insmed Unusual Options Activity For July 11
Benzinga Insights
Wednesday, July 10, 2024
Goldman Sachs Maintains Buy on Insmed, Raises...
Benzinga Newsdesk
Tuesday, July 09, 2024
Guggenheim Maintains Buy on Insmed, Raises Pr...
Benzinga Newsdesk
Monday, July 08, 2024
American Express To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
